For Financial Professionals in the US
We believe in the sharing of expert insight for better investment and business decisions. We call this ethos Knowledge Shared.
Biopharma’s Targeted Approach to Growth
A new drug targeting a common mutation found in tumors represents a breakthrough in cancer therapy and a potential new source of growth for biopharma.
Subscribe for relevant insights delivered straight to your inbox
Interpreting the data in China’s latest census, with a focus on pressing economic and societal issues.
The COVID-19 pandemic has likely exposed both the winners and pretenders in emerging markets, explains Daniel Graña.
The impact of “re-shoring” and rising cross-border flows on Chinese markets.
Considering the massive investment implications of China’s decarbonization plan.
China equities manager May Ling Wee highlights the key opportunities and risks facing the asset class in 2021.
Daniel Graña argues that country analysis should remain a key focus for emerging market investors given the implications from COVID-19 and a less supportive international trade environment.
A discussion of the main highlights for investors in China stocks over the first half of the year and the outlook for the rest of 2020.
China Equities Portfolio Manager May Ling Wee discusses sectors in China that she believes could represent attractive investment opportunities.